HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Industrial Cannabis/Industrial Hemp

462.913

-13.630-2.86%

Number of Gainers:4

Number of Losers:2

Number of Flat:1

PE:- -

High:485.051

Open:476.543

Low:458.202

Close:476.543

Volume:133.46M

Turnover:121.29M

Market Cap:18.98B

Float Cap:18.98B

Loading ...

Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand

China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%

Sihuan Pharma FY26 H1 Profit Attributable to Owners Rises 119% to RMB 224.7 Million; Revenue Increases 1.3% to RMB 1.16 Billion

Sihuan Pharmaceutical Files Board, Committee Roles and Disclosure-Responsible Management List

SIHUAN PHARM Posts 119% Profit Surge in Interim Results, Reinforcing Dual-Engine Strategy

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Sihuan Pharmaceutical Holdings Group H1 Net Income Attributable RMB 224.7 Million

THOMSON REUTERS

Sihuan Pharma Appoints Song Xiaomi as CFO

Sihuan Pharma - Appoints Song Xiaomi as Chief Financial Officer Effective 26 August 2026

THOMSON REUTERS

Sihuan Pharma - Miao Guili Resigns as Executive Director, Deputy CEO, and CFO Effective 26 August 2026

THOMSON REUTERS

Grandshores Technology Controlling Shareholder’s Beneficial Ownership Holds 30.56% Stake Via Morgan Hill

China Carbon Neutral Development Group Auditor Changes Name to CLA Prism Hong Kong

EVERGREEN PG Sets September Payout for Interim Dividend of HK$0.034 Per Share

EVERGREEN PG Reports Strong Interim Results with 75.5% Profit Surge

Evergreen Products Declares Interim Dividend of HKD 0.034 a Share

Hong Kong Stock Movers | Sihuan Pharma Surges Over 6% on Strong H1 Profit Forecast and Expanding Aesthetic Medicine Business

YNBY International (SEHK:30) Stock Carries A Premium As Margins Stay Thin

Simply Wall St.

YNBY International H1 FY26 Profit Attributable to Owners Rises 13.31% to HK$ 2.69 Million; Revenue More than Doubled to HK$ 762.54 Million

Xuanzhu Biopharmaceutical Sets Board Meeting to Review Interim Results

Meilleure Health Sets Board Meeting to Review Interim Results, Consider Dividend

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketb.com/stock/BK1600/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"BK1600","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","market":"HK","secType":"PLATE","nameCN":"Industrial Cannabis/Industrial Hemp","latestPrice":462.91263,"timestamp":1787731681268,"preClose":476.54312,"halted":0,"volume":133457000,"delay":0,"changeRate":-0.028603,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-13.630493,"latestTime":"08-26 16:00:00","open":476.54312,"high":485.05103,"low":458.2015,"amount":121292909,"amplitude":0.056342,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787794200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787707800000,1787716800000],[1787720400000,1787731200000]],"pbRate":1.405618,"peRate":38.950574,"turnoverRate":0.004365,"increases":4,"decrements":2,"flats":1,"marketCap":18979085680,"floatMarketCap":18979085680},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","high":485.05103,"amplitude":0.056342,"preClose":476.54312,"low":458.2015,"pbRate":"1.405618","latestPrice":462.91263,"volume":133457000,"delay":0,"open":476.54312,"prevYearClose":572.4504,"prevWeekClose":475.684,"prevMonthClose":486.869,"prevQuarterClose":454.412,"fiveDayClose":465.703,"twentyDayClose":484.625,"sixtyDayClose":519.478,"secType":"PLATE","market":"HK","turnoverRate":0.004365,"peRate":38.950574,"marketCap":18979085680,"floatMarketCap":18979085680,"timestamp":1787731681268,"nameCN":"Industrial Cannabis/Industrial Hemp"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1600\",,,,undefined,":{"bkCode":"BK1600","up":4,"down":2,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1600\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662717592","title":"Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2662717592","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662717592?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:54","pubTimestamp":1787752465,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical H1 revenue rises on nuclear medicine demandOverviewHong Kong-listed pharma group's H1 revenue rose 3.2% yr/yr to HK$6.39 blnNet income attributable to owners fell to HK$1.06 bln f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1515","03692","00512","00460","BK1593","BK1600","BK1583","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662715194","title":"China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662715194","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662715194?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:36","pubTimestamp":1787744170,"startTime":"0","endTime":"0","summary":"China's Zhongzhi Pharmaceutical H1 revenue falls 10%OverviewChina pharmaceutical maker's half-year revenue fell 10.3% yr/yrProfit attributable to owners rose 3.8% yr/yrGross profit and margin declined","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","01681","03692","BK1600","BK1593","BK1589","BK1515","BK1606","BK1191","03737","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662973617","title":"Sihuan Pharma FY26 H1 Profit Attributable to Owners Rises 119% to RMB 224.7 Million; Revenue Increases 1.3% to RMB 1.16 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662973617","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662973617?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:08","pubTimestamp":1787738933,"startTime":"0","endTime":"0","summary":"Sihuan Pharma FY26 H1 profit attributable to owners rises 119% to RMB 224.7 million; revenue increases 1.3% to RMB 1.16 billionSihuan Pharmaceutical posted profit attributable to owners of RMB 224.7 m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLc1wDYT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1515","00460","BK1191","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662794653","title":"Sihuan Pharmaceutical Files Board, Committee Roles and Disclosure-Responsible Management List","url":"https://stock-news.laohu8.com/highlight/detail?id=2662794653","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662794653?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:38","pubTimestamp":1787737093,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical files board, committee roles and disclosure-responsible management listSihuan Pharmaceutical named Che Fengsheng as chairman; Guo Weicheng as vice chairman, chief executive; exec","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL1yGHl8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","00460","BK1515","BK1600","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191993997","title":"SIHUAN PHARM Posts 119% Profit Surge in Interim Results, Reinforcing Dual-Engine Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1191993997","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191993997?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:36","pubTimestamp":1787718981,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) has reported its interim results for the six months ended June 30, 2026, showcasing a substantial jump in profitability. The group recorded a total revenue of RMB 1.161 billion,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK1574","LNGR","BK1515","BK1600","BK1593","BK1161","IBBQ","06978","00460","BK1191","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662176420","title":"Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2662176420","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662176420?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:15","pubTimestamp":1787717732,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical H1 profit jumps on medical aesthetics unit strengthOverviewChina pharmaceutical group's interim revenue rose 1.3% yr/yr, led by medical aesthetics growthNet income attributable t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N039:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2097828631.EUR","LU2328871848.SGD","688428","LU1226288253.USD","LU2242644610.SGD","LU2488822045.USD","BK1583","HK0000165453.HKD","LU1226288170.HKD","LU0455707207.USD","LU1226287529.USD","IE00B031HY20.USD","IE0008369823.USD","LU2097828714.EUR","LU0067412154.USD","IE00BZ08YS42.EUR","01801","LU0244354667.USD","BK1515","LU1152091754.HKD","LU0501845795.SGD","LU1969619763.USD","SG9999004220.SGD","LU0140636845.USD","KURE","LU0314109678.HKD","LU1813983027.USD","01093","00460","BK1191","BK1600","LU1152091168.USD","IE00B5MMRT66.SGD","LU1328277881.USD","BK1593","BK1589","LU0072913022.USD","IE00B543WZ88.USD","LU0463099449.HKD","BK0239","LU2097828474.EUR","LU1960683339.HKD","LU0502904849.HKD","LU1807302812.USD","LU0880133367.SGD","LU1188198961.HKD","LU2097828805.USD","LU1008478684.HKD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662641907","title":"Sihuan Pharmaceutical Holdings Group H1 Net Income Attributable RMB 224.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662641907","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662641907?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:04","pubTimestamp":1787717060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nPLXL73S0P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","BK1191","BK1600","00460","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662776415","title":"Sihuan Pharma Appoints Song Xiaomi as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2662776415","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662776415?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:02","pubTimestamp":1787716971,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Appoints Song Xiaomi As CFOAug 26 (Reuters)-Sihuan Pharmaceutical0460.HK:APPOINTS SONG XIAOMI AS CHIEF FINANCIAL OFFICER EFFECTIVE 26 AUGUST 2026MIAO GUILI RESIGNS AS EXECUTIVE DIRECTOR, DEPUTY CEO, AND CFO EFFECTIVE 26 AUGUST 2026Further company coverage:0460.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N002:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1515","BK1593","BK1600","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662641837","title":"Sihuan Pharma - Appoints Song Xiaomi as Chief Financial Officer Effective 26 August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662641837","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662641837?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:01","pubTimestamp":1787716878,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N002:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","BK1515","BK1600","00460","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662764909","title":"Sihuan Pharma - Miao Guili Resigns as Executive Director, Deputy CEO, and CFO Effective 26 August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662764909","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662764909?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:00","pubTimestamp":1787716853,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44M0W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1600","00460","BK1515","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662733450","title":"Grandshores Technology Controlling Shareholder’s Beneficial Ownership Holds 30.56% Stake Via Morgan Hill","url":"https://stock-news.laohu8.com/highlight/detail?id=2662733450","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662733450?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:11","pubTimestamp":1787652715,"startTime":"0","endTime":"0","summary":"Grandshores Technology controlling shareholder’s beneficial ownership holds 30.56% stake via Morgan HillGrandshores controlling shareholder vehicle Great Scenery plans to shift beneficial ownership to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL69tVHr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1612","BK1148","01647"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662978076","title":"China Carbon Neutral Development Group Auditor Changes Name to CLA Prism Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2662978076","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662978076?lang=en_us&edition=fundamental","pubTime":"2026-08-25 17:34","pubTimestamp":1787650492,"startTime":"0","endTime":"0","summary":"China Carbon Neutral Development Group auditor changes name to CLA Prism Hong KongChina Carbon Neutral Development Group reported a name change of its auditor, effective Aug. 21, 2026.Audit firm renam","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL7qJwSm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1594","BK1144","BK1600","01372","BK1148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141126483","title":"EVERGREEN PG Sets September Payout for Interim Dividend of HK$0.034 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1141126483","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141126483?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:03","pubTimestamp":1787572988,"startTime":"0","endTime":"0","summary":"EVERGREEN PG (01962) has announced the distribution of an interim dividend for the six-month period ended June 30, 2026, with payment scheduled for September 23, 2026.Shareholders on record will...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1207","BK1600","VIG","BK4585","01962","BK4588","EWH","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178849036","title":"EVERGREEN PG Reports Strong Interim Results with 75.5% Profit Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1178849036","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178849036?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:54","pubTimestamp":1787572455,"startTime":"0","endTime":"0","summary":"EVERGREEN PG (01962) has announced its interim results for the 2026 fiscal year, showcasing robust financial performance driven by resilient global demand in the wig market.The company recorded...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01962","BK1585","BK1600","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275249","title":"Evergreen Products Declares Interim Dividend of HKD 0.034 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275249","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275249?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:50","pubTimestamp":1787572220,"startTime":"0","endTime":"0","summary":"Evergreen Products declares interim dividend of HKD 0.034 a shareEvergreen Products Group declared an interim dividend of HKD 0.034 per share for the six months ended June 30, 2026.Shares trade ex-dividend on Sept. 7.Record date set for Sept. 11.Dividend payable on Sept. 23.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evergreen Products Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on August 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL6zRZhh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348814723.USD","LU1098665638.USD","LU1023061713.HKD","LU0327786744.USD","LU0540923850.HKD","LU1105468828.SGD","LU1003076772.USD","BK1585","LU1153584641.USD","HSBA.UK","LU0572940350.SGD","LU2539964713.USD","LU0307460666.USD","LU0211328371.USD","LU0264606111.USD","LU0572939691.SGD","LU0607220059.USD","LU0827474353.SGD","LU1019632923.USD","LU0164880469.USD","LU1770036033.HKD","LU0171281750.USD","LU0345776255.USD","LU0572944931.SGD","BK1600","IE0034235071.USD","LU0964806797.USD","LU0920840948.USD","BK5152","BK1207","LU0575583348.USD","LU0516422952.EUR","LU2114397693.USD","IE0008369823.USD","LU0211327993.USD","LU1019634622.SGD","LU0345775950.USD","LU2293690249.USD","LU0634319403.HKD","LU0348816934.USD","LU1015430645.USD","LU0857590862.USD","LU2449936058.SGD","LU0149534421.HKD","LU0516423174.USD","LU1046234339.USD","LU0920783379.SGD","01962","LU1481107354.HKD","LU0797268264.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156555320","title":"Hong Kong Stock Movers | Sihuan Pharma Surges Over 6% on Strong H1 Profit Forecast and Expanding Aesthetic Medicine Business","url":"https://stock-news.laohu8.com/highlight/detail?id=1156555320","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156555320?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:24","pubTimestamp":1787207055,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) shares climbed more than 6% in Hong Kong trading on Tuesday, with the stock last up 6.47% at HK$0.905, on turnover of HK$36.93 million.The rally follows the company's positive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1593","BK4588","VXUS","BK1191","BK4585","KCAI","00460","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659174465","title":"YNBY International (SEHK:30) Stock Carries A Premium As Margins Stay Thin","url":"https://stock-news.laohu8.com/highlight/detail?id=2659174465","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659174465?lang=en_us&edition=fundamental","pubTime":"2026-08-16 14:26","pubTimestamp":1786861594,"startTime":"0","endTime":"0","summary":"YNBY International stock closed at HK$0.246 on Friday after a modest positive run in recent weeks, yet the real story sits inside the latest half year numbers. The market is reacting to a consumer retailer that now carries a premium P/S of 2.1x against much cheaper Hong Kong peers, while net profit margins over the past year sit at only 0.4%.\nThat combination of thin profitability and rich valuation is the headline for these H1 2026 results. Short term traders are watching the price chart...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/5022000-choice2-main-header/1585187227473","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5022000-choice2-main-header/1585187227473"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-30/ynby-international-shares/news/ynby-international-sehk30-stock-carries-a-premium-as-margins","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-30/ynby-international-shares/news/ynby-international-sehk30-stock-carries-a-premium-as-margins","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1121","00030","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659114547","title":"YNBY International H1 FY26 Profit Attributable to Owners Rises 13.31% to HK$ 2.69 Million; Revenue More than Doubled to HK$ 762.54 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659114547","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659114547?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:28","pubTimestamp":1786706886,"startTime":"0","endTime":"0","summary":"YNBY International H1 FY26 profit attributable to owners rises 13.31% to HK$ 2.69 million; revenue more than doubled to HK$ 762.54 millionYNBY International posted profit attributable to owners of HK$","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL8Ky8lm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0164","BK0196","LU1807302812.USD","000538","BK1600","00030","LU1960683339.HKD","BK0175","BK0187","BK0188","LU1993786604.SGD","BK1121","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659155279","title":"Xuanzhu Biopharmaceutical Sets Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659155279","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659155279?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:57","pubTimestamp":1786618663,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical sets board meeting to review interim resultsXuanzhu Biopharmaceutical will hold a board meeting on Aug. 26, 2026.Directors will review interim results for the six months ende","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL3w6dBz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575","BK1593","BK1515","BK1191","00460","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659137244","title":"Meilleure Health Sets Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2659137244","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659137244?lang=en_us&edition=fundamental","pubTime":"2026-08-13 17:05","pubTimestamp":1786611925,"startTime":"0","endTime":"0","summary":"Meilleure Health sets board meeting to review interim results, consider dividendMeilleure Health set a board meeting for Aug. 27, 2026.Directors will review interim results for the six months ended Ju","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL5lQrjS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1124","02327","BK1600"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}]}}